Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 27;10(8):1198.
doi: 10.3390/vaccines10081198.

Overview of Tools and Measures Investigating Vaccine Hesitancy in a Ten Year Period: A Scoping Review

Affiliations

Overview of Tools and Measures Investigating Vaccine Hesitancy in a Ten Year Period: A Scoping Review

Elizabeth O Oduwole et al. Vaccines (Basel). .

Abstract

The challenge of vaccine hesitancy, a growing global concern in the last decade, has been aggravated by the COVID-19 pandemic. The need for monitoring vaccine sentiments and early detection of vaccine hesitancy in a population recommended by the WHO calls for the availability of contextually relevant tools and measures. This scoping review covers a ten year-period from 2010-2019 which included the first nine years of the decade of vaccines and aims to give a broad overview of tools and measures, and present a summary of their nature, similarities, and differences. We conducted the review using the framework for scoping reviews by Arksey and O'Malley (2005) and reported it following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews' guidelines. Of the 26 studies included, only one was conducted in the WHO African Region. Measures for routine childhood vaccines were found to be the most preponderant in the reviewed literature. The need for validated, contextually relevant tools in the WHO Africa Region is essential, and made more so by the scourge of the ongoing pandemic in which vaccination is critical for curtailment.

Keywords: immunization; measures; scoping review; tools; vaccination; vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
PRISMA flow diagram for the study selection process.
Figure 2
Figure 2
Number of included studies per WHO region and country.

References

    1. Stratford J., MacKenzie E., Mockford E. Balancing Speed and Safety: The Authorisation of COVID-19 Vaccines and Medicines. Judic. Rev. 2020;25:105–117. doi: 10.1080/10854681.2020.1780664. - DOI
    1. Razai M.S., Oakeshott P., Esmail A., Wiysonge C.S., Viswanath K., Mills M.C. COVID-19 vaccine hesitancy: The five Cs to tackle behavioural and sociodemographic factors. J. R. Soc. Med. 2021;114:295–298. doi: 10.1177/01410768211018951. - DOI - PMC - PubMed
    1. Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601. - DOI - PMC - PubMed
    1. Cooper S., Betsch C., Sambala E.Z., Mchiza N., Wiysonge C.S. Vaccine hesitancy–a potential threat to the achievements of vaccination programmes in Africa. Hum. Vaccines Immunother. 2018;14:2355–2357. doi: 10.1080/21645515.2018.1460987. - DOI - PMC - PubMed
    1. MacDonald N.E., Eskola J., Liang X., Chaudhuri M., Dube E., Gellin B., Goldstein S., Larson H., Manzo M.L., Reingold A. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036. - DOI - PubMed

Publication types

LinkOut - more resources